NASDAQ
NovaBay Pharmaceuticals, Inc. (NBY) has a current ratio of 7.60x as of Monday, May 25, 2026. This represents a 243.68% increase compared to its 12-month average of 2.21x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.